SBI Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.5K Sell
128
-6
-4% -$2.23K ﹤0.01% 1163
2026
Q1
$39.2K Buy
134
+13
+11% +$4.27K ﹤0.01% 1190
2025
Q4
$42.4K Sell
121
-706
-85% -$239K ﹤0.01% 1148
2025
Q3
$267K Buy
827
+508
+159% +$158K 0.01% 555
2025
Q2
$124K Sell
319
-2,211
-87% -$889K ﹤0.01% 743
2025
Q1
$1.1M Buy
2,530
+34
+1% +$13.6K 0.04% 239
2024
Q4
$921K Buy
+2,496
New +$1.04M 0.03% 256

Other funds holding ELV

SBI Securities's ELV Position: Q2 2026 in Review

SBI Securities reduced its Elevance Health (ELV) stake by 4.5% in Q2 2026, selling an estimated $2.23K and leaving 128 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.

SBI Securities first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.1M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • SBI Securities held 128 shares of Elevance Health worth $49.5K as of Q2 2026.
  • SBI Securities sold 6 Elevance Health shares in Q2 2026, an estimated $2.23K.
  • Elevance Health made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1163 holding.
  • SBI Securities first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Elevance Health position peaked at $1.1M in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.